190 related articles for article (PubMed ID: 19371177)
1. European pharmaceutical pricing and reimbursement conference.
Ehreth J; Williams D
Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):37-9. PubMed ID: 19371177
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical Pricing and Market Access Outlook Europe 2010-HealthNetwork Communications' fourth annual conference. 24-25 March 2010, London, UK.
Ogbighele E
IDrugs; 2010 May; 13(5):317-20. PubMed ID: 20432188
[TBL] [Abstract][Full Text] [Related]
3. New developments in pricing and drug reimbursement in France.
Pelc A; Castan JP
Pharmacoeconomics; 1994; 6 Suppl 1():28-35. PubMed ID: 10155583
[TBL] [Abstract][Full Text] [Related]
4. Access to orphan drugs in Europe: current and future issues.
Michel M; Toumi M
Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):23-9. PubMed ID: 22280193
[TBL] [Abstract][Full Text] [Related]
5. The pricing and reimbursement of pharmaceuticals.
Towse A
Pharmacoeconomics; 1994; 6 Suppl 1():36-8. PubMed ID: 10155584
[TBL] [Abstract][Full Text] [Related]
6. Pharma Pricing & Market Access Europe 2016--Health Network Communications' Tenth Annual Conference (February 23-25, 2016--London, UK).
D'Souza P
Drugs Today (Barc); 2016 Mar; 52(3):203-6. PubMed ID: 27186595
[TBL] [Abstract][Full Text] [Related]
7. European Pharmaceutical Pricing and Reimbursement--SMi's 21st Annual Meeting (October 5-6, 2015--London, UK).
Kibble A; D'Souza P
Drugs Today (Barc); 2015 Oct; 51(10):609-12. PubMed ID: 26583303
[TBL] [Abstract][Full Text] [Related]
8. Pricing and reimbursement of orphan drugs: the need for more transparency.
Simoens S
Orphanet J Rare Dis; 2011 Jun; 6():42. PubMed ID: 21682893
[TBL] [Abstract][Full Text] [Related]
9. When are Pharmaceuticals Priced Fairly? An Alternative Risk-Sharing Model for Pharmaceutical Pricing.
Balderrama F; Schwartz LJ; Longo CJ
Health Care Anal; 2020 Jun; 28(2):121-136. PubMed ID: 32232611
[TBL] [Abstract][Full Text] [Related]
10. [Health technology assessment and its impact on pharmaceutical pricing and reimbursement policies].
Castillo-Laborde C; Silva-Illanes N
Rev Med Chil; 2014 Jan; 142 Suppl 1():S33-8. PubMed ID: 24861178
[TBL] [Abstract][Full Text] [Related]
11. Recent public policies in The Netherlands to control pharmaceutical pricing and reimbursement.
Rigter H
Pharmacoeconomics; 1994; 6 Suppl 1():15-21. PubMed ID: 10155581
[TBL] [Abstract][Full Text] [Related]
12. [Risk sharing methods in middle income countries].
Inotai A; Kaló Z
Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
[TBL] [Abstract][Full Text] [Related]
13. Review of regulatory recommendations for orphan drug submissions in the Netherlands and Scotland: focus on the underlying pharmacoeconomic evaluations.
Vegter S; Rozenbaum MH; Postema R; Tolley K; Postma MJ
Clin Ther; 2010 Aug; 32(9):1651-61. PubMed ID: 20974323
[TBL] [Abstract][Full Text] [Related]
14. Policies and availability of orphan medicines in outpatient care in 24 European countries.
Sarnola K; Ahonen R; Martikainen JE; Timonen J
Eur J Clin Pharmacol; 2018 Jul; 74(7):895-902. PubMed ID: 29632962
[TBL] [Abstract][Full Text] [Related]
15. Public policy trends in drug pricing and reimbursement in the European Community.
Redwood H
Pharmacoeconomics; 1994; 6 Suppl 1():3-10. PubMed ID: 10172481
[TBL] [Abstract][Full Text] [Related]
16. Regulation. Bill due for drugmakers' winning strategy.
Lee J
Mod Healthc; 2014 Jun; 44(22):10. PubMed ID: 24946373
[No Abstract] [Full Text] [Related]
17. Reimbursement of orphan drugs in Belgium: what (else) matters?
Picavet E; Cassiman D; Simoens S
Orphanet J Rare Dis; 2014 Sep; 9():139. PubMed ID: 25208770
[TBL] [Abstract][Full Text] [Related]
18. Getting to the Root of High Prescription Drug Prices.
Waxman H; Corr B; Martin K; Duong S
Issue Brief (Commonw Fund); 2017 Jul; 2017():1-10. PubMed ID: 28700190
[TBL] [Abstract][Full Text] [Related]
19. Pricing and reimbursement of pharmaceuticals in Sweden.
Jönsson B
Pharmacoeconomics; 1994; 6 Suppl 1():51-60. PubMed ID: 10172482
[TBL] [Abstract][Full Text] [Related]
20. Support system: through charities, drug makers help people--and themselves.
Anand G
Wall St J (East Ed); 2005 Dec; ():A1, A10. PubMed ID: 16502554
[No Abstract] [Full Text] [Related]
[Next] [New Search]
